Heparan sulfate facilitates Rift Valley fever virus entry into the cell

Publication date

2012

Authors

de Boer, S.M.ISNI 0000000419432495
Kortekaas, J.
de Haan, Cornelis A MORCID 0000-0002-4459-9874ISNI 0000000395765470
Rottier, P.J.M.ISNI 0000000029654607
Moormann, RobISNI 000000039524814X
Bosch, Berend-JanISNI 0000000387346575

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

Abstract

Rift Valley fever virus (RVFV), an emerging arthropod-borne pathogen, has a broad host and cell tropism. Here we report that the glycosaminoglycan heparan sulfate, abundantly present on the surface of most animal cells, is required for efficient entry of RVFV. Entry was significantly reduced by preincubating the virus inoculum with highly sulfated heparin, by enzymatic removal of heparan sulfate from cells and in cells genetically deficient in heparan sulfate synthesis.

Keywords

Citation

de Boer, S M, Kortekaas, J, de Haan, C A M, Rottier, P J M, Moormann, R J M & Bosch, B J 2012, 'Heparan sulfate facilitates Rift Valley fever virus entry into the cell', Journal of Virology, vol. 86, no. 24, pp. 13767-13771. https://doi.org/10.1128/JVI.01364-12